You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
A note on Brauer-Schur functions / Kazuya Aokage, Hiroshi Mizukawa and Hiro-Fumi Yamada -- [symbol]-operators on associative algebras, associative Yang-Baxter equations and dendriform algebras / Chengming Bai, Li Guo and Xiang Ni -- Irreducible Wakimoto-like modules for the affine Lie algebra [symbol] / Yun Gao and Ziting Zeng -- Verma modules over generic exp-polynomial Lie algebras / Xiangqian Guo, Xuewen Liu and Kaiming Zhao -- A formal infinite dimensional Cauchy problem and its relation to integrable hierarchies / G.F. Helminck, E.A. Panasenko and A.O. Sergeeva -- Partially harmonic tensors and quantized Schur-Weyl duality / Jun Hu and Zhankui Xiao -- Quantum entanglement and approximation by positive matrices / Xiaofen Huang and Naihuan Jing -- 2-partitions of root systems / Bin Li, William Wong and Hechun Zhang -- A survey on weak Hopf algebras / Fang Li and Qinxiu Sun -- The equitable presentation for the quantum algebra Uq(f(k)) / Yan Pan, Meiling Zhu and Libin Li
This volume contains the proceedings of the AMS Special Session on Representations of Lie Algebras, Quantum Groups and Related Topics, held from November 12–13, 2016, at North Carolina State University, Raleigh, North Carolina. The articles cover various aspects of representations of Kac–Moody Lie algebras and their applications, structure of Leibniz algebras and Krichever–Novikov algebras, representations of quantum groups, and related topics.
Despite many years of translational research in breast cancer, very few new biomarkers have been implemented for clinical use beyond estrogen receptor, progesterone receptor, and HER2. The main reason is that many promising biomarkers are clinically validated but lack analytical and clinical utility. One explanation is that proper validation of the predictive ability of the biomarker in independent datasets, and with a pre-planned statistical analysis, is not always performed. Thus, there is a need to identify new biomarkers or new ways to subclassify breast cancer patients that are reproducible and easy to implement in the clinical setting but, more importantly, that improve patient’s outcomes.
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.
This eBook is a collection of articles from a Frontiers Research Topic. Frontiers Research Topics are very popular trademarks of the Frontiers Journals Series: they are collections of at least ten articles, all centered on a particular subject. With their unique mix of varied contributions from Original Research to Review Articles, Frontiers Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author by contacting the Frontiers Editorial Office: frontiersin.org/about/contact.
Based on documents published in China, this book examines the reasons behind the Chinese Communists’ success during the Sino-Japanese War demythologizing Maoist guerrilla warfare by revealing the links between the Communists’ military and financial might during the Japanese occupation.
After several decades of development, the socialist market economy of China is now the world’s second largest economy by nominal GDP. China is also the largest economy by purchasing power parity according to the International Monetary Fund. In tandem with the development of the Chinese economy, China’s cancer burden is rising rapidly due to an ageing population and the adoption of unhealthy lifestyle behaviours. According to the data from the National Central Cancer Registry (NCCR) of China, the incidence and mortality of cancer have been increasing rapidly in China. In recent years, cancer has been the leading cause of death among city residents and the second cause of death among rural...